eudamed_udi
Primary ID: 03532672000219
i-Tracker Anti-Ocrelizumab (UDI 03532672000219)
Manufactured by BIOSYNEX
Data verified against official FDA/EUDAMED records on
Scannable UDI-DI Representation
GS1-128 UDI Barcode representation for i-Tracker Anti-Ocrelizumab - Primary ID 03532672000219
Device Regulatory Overview
The i-Tracker Anti-Ocrelizumab (Model/Catalog Number: CTO 003-50) is a medical device manufactured by BIOSYNEX. This product is indexed under FDA Product Code / Category Classification W0102080799 within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- CTO 003-50
- Product Code / EMDN
- W0102080799
- Device Name
- i-Tracker Anti-Ocrelizumab
- Database Sync Date
- 2026-08-09 16:28:48
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of i-Tracker Anti-Ocrelizumab?
The registered manufacturer of record for i-Tracker Anti-Ocrelizumab is BIOSYNEX.
What is the Primary UDI-DI identifier for i-Tracker Anti-Ocrelizumab?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 03532672000219.
What classification code is assigned to this device?
This device is registered under product classification code W0102080799.
Similar Classification Devices (W0102080799)
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint